Nutrien (NTR) Stock Price, News & Analysis

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last twelve months. There are currently 2 sell ratings, 6 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NTR, but not buy additional shares or sell existing shares.
View NTR analyst ratings or view top-rated stocks.

19 Wall Street research analysts have issued 1-year target prices for Nutrien's stock. Their NTR share price targets range from $48.00 to $85.00. On average, they expect the company's share price to reach $67.95 in the next twelve months. This suggests a possible upside of 31.2% from the stock's current price.
View analysts price targets for NTR or view top-rated stocks among Wall Street analysts.

Nutrien's stock was trading at $56.33 at the start of the year. Since then, NTR stock has decreased by 8.0% and is now trading at $51.81.
View the best growth stocks for 2024 here.

Nutrien saw a increase in short interest in March. As of March 31st, there was short interest totaling 4,700,000 shares, an increase of 50.6% from the March 15th total of 3,120,000 shares. Based on an average daily volume of 2,110,000 shares, the days-to-cover ratio is presently 2.2 days. Currently, 1.0% of the company's stock are short sold.
View Nutrien's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our NTR earnings forecast.

Nutrien will be holding an earnings conference call on Thursday, May 9th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 888-660-6264 with passcode "44874#".

Nutrien Ltd. (NYSE:NTR) issued its earnings results on Wednesday, February, 21st. The company reported $0.37 EPS for the quarter, missing analysts' consensus estimates of $0.72 by $0.35. The business earned $5.66 billion during the quarter, compared to analyst estimates of $5.36 billion. Nutrien had a trailing twelve-month return on equity of 8.59% and a net margin of 4.33%. Nutrien's revenue for the quarter was down 24.8% on a year-over-year basis. During the same quarter last year, the firm earned $2.02 earnings per share.

Nutrien declared a quarterly dividend on Wednesday, February 21st. Investors of record on Thursday, March 28th will be paid a dividend of $0.54 per share on Thursday, April 11th. This represents a $2.16 annualized dividend and a dividend yield of 4.17%. The ex-dividend date is Wednesday, March 27th. This is an increase from the stock's previous quarterly dividend of $0.53.
Read our dividend analysis for NTR.

Nutrien (NYSE:NTR) pays an annual dividend of $2.16 per share and currently has a dividend yield of 4.13%. NTR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 85.38%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, NTR will have a dividend payout ratio of 55.24% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NTR.

ETFs with the largest weight of Nutrien (NYSE:NTR) stock in their portfolio include Global X AgTech & Food Innovation ETF (KROP), VanEck Agribusiness ETF (MOO), iShares MSCI Agriculture Producers ETF (VEGI), FlexShares Global Upstream Natural Resources Index Fund (GUNR), SPDR S&P North American Natural Resources ETF (NANR), SPDR S&P Global Natural Resources ETF (GNR), iShares Emergent Food and AgTech Multisector ETF (IVEG) and Invesco International Dividend Achievers ETF (PID).

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Nutrien's stock is owned by a number of retail and institutional investors. Top institutional shareholders include ARGA Investment Management LP (0.76%), Miller Howard Investments Inc. NY (0.13%), Addenda Capital Inc. (0.11%), Cardinal Capital Management Inc. (0.11%), Galibier Capital Management Ltd. (0.09%) and IMC Chicago LLC (0.00%).

Shares of NTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.